Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...

First Mining Gold said that it will sell its remaining stake in a Newfoundland mining project to Big Ridge Gold in a cash and stock deal. The miner said Monday it entered into an agreement with Big ...

NWTN Inc. named Adrian Wong as chief financial officer and John Xie as chief operating officer. The smart technology company on Monday said both appointments are effective as of July 3. The ...

The question has ignited fresh debate online as recent economic data has shown that many young graduates — even those with ...

The technology company, which focuses on Bitcoin mining using immersion technology, said after Thursday's closing bell that it entered agreements with certain accredited investors to sell roughly 36.3 ...

The National Highway Traffic Safety Administration said the Office of Defects Investigation is opening a recall query following consumer reports describing post-recall remedy failures in certain Ram ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...

Here are some of the notable share price movers in Monday's premarket action. Tesla shares are down more than 6% as investors fret Elon Musk's pledge to launch a political party [will impact badly on ...

Molina Healthcare reduced its outlook for the year, citing short-term earnings pressure that it expects to continue into the second half of the year.

Thailand shares reversed a one-day losing streak Monday, with the composite Thailand SET Index SET +0.27% gaining 0.3% to 1,123.00.

The company said after Thursday's closing bell that the agreement will allow the company to strategically raise and deploy capital. The per-share price that Yorkville will pay for the shares will be a ...

Apogee Therapeutics shares soared in premarket trading Monday after the company said it received positive trial data for its atopic dermatitis treatment. Shares traded 36% higher ahead of the morning ...